BioSpace News Archive

Deals

GlycoMimetics Announces Its Addition to the Russell Microcap® Index

GlycoMimetics, Inc. today announced that it is set to join the Russell Microcap Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the U.S. market opens on June 26, 2023.

June 26, 2023
·
2 min read
Genetown

Cognito Therapeutics Announces Scientific Presentations at the Alzheimer’s Association International Conference 2023

Cognito Therapeutics today announced that it will present four scientific abstracts at the Alzheimer’s Association International Conference 2023 (AAIC).

June 26, 2023
·
2 min read
Deals

Acorda Therapeutics Regains Compliance with Nadaq Minimum Bid Price Requirement

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has received notification from the Nasdaq Stock Market informing the Company that as of June 20, 2023 it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1).

June 26, 2023
·
4 min read
Business

Biotricity to Host Fiscal Year 2023 Financial Results and Business Update Call on June 30th

Biotricity Inc. announced that it will host its Fiscal Year 2023 Financial Results and Business Update Call on Friday, June 30, 2023.

June 26, 2023
·
4 min read
BioMidwest

Panbela Announces Poster Presentation at the Endocrine Society Meeting: Polyamine Inhibition and β-Cell Preservation in Recent Onset Type 1 Diabetes

Panbela Therapeutics, Inc announces a poster presentation highlighting the results for CPP-1X (also known as α-Difluoromethylornithine (DFMO) or Eflornithine) in recent onset type 1 diabetes at the Endocrine Society meeting, which was held June 15-18, 2023.

June 26, 2023
·
8 min read
Deals

Reneo Pharmaceuticals Added to Russell 2000® and Russell 3000® Indices

Reneo Pharmaceuticals, Inc. today announced that it has been added to the broad-market Russell 3000® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, according to a preliminary list of additions posted May 19.

June 26, 2023
·
3 min read
OMAPiX Announces Strategic Partnerships with Leading Spatial Biology Platform Providers to Accelerate Life Science Research and Drug Development

OMAPiX announced strategic partnerships with Vizgen, Inc., Resolve Biosciences, and Ultivue, Inc.

June 26, 2023
·
4 min read
Genetown

Cerevance Announces Presentation at the Gordon Research Conference: Amyotrophic Lateral Sclerosis and Related Motor Neuron Diseases

Cerevance today announced plans to present a poster presentation at the upcoming Gordon Research Conference: Amyotrophic Lateral Sclerosis (ALS) and Related Motor Neuron Diseases, taking place in Les Diablerets, VD, Switzerland, July 2 – July 7, 2023.

June 26, 2023
·
2 min read
Deals

Zymeworks Set to Join Russell 3000®, Russell 2000®, and Russell Microcap® Indexes

Zymeworks Inc. today announced that it is set to join both the Russell 3000®, Russell 2000 ® , and the Russell Microcap® Indexes at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the U.S. market opens on June 26, 2023.

June 26, 2023
·
5 min read
Deals

Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes

Wave Life Sciences Ltd. today announced that the company has been added to the small-cap Russell 2000® and broad-market all-cap Russell 3000® Indexes as part of the annual reconstitution, effective after the U.S. market opens today, June 26, 2023.

June 26, 2023
·
1 min read